PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933340
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933340
Cardiology Positron Emission Tomography Scan Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of cardiology positron emission tomography (PET) scan Market
The global cardiology positron emission tomography (PET) scan market was valued at USD 1.93 billion in 2025 and is projected to grow to USD 1.98 billion in 2026, reaching USD 2.83 billion by 2034, registering a CAGR of 4.55% during the forecast period. Cardiac PET is a non-invasive imaging procedure that uses radioactive tracers to evaluate heart metabolism, myocardial perfusion, inflammation, and viability. These scans are critical for diagnosing coronary artery disease (CAD), evaluating heart damage post-heart attack, and planning surgical procedures such as bypass surgeries.
North America dominated the market in 2025 with a 10.73% share, driven by the rising prevalence of cardiac conditions, advanced healthcare infrastructure, and continual technological advancements in imaging systems. Key players in the market include Sonic Healthcare Limited, Apex Radiology, Alliance Medical, and Siemens Healthcare Limited, which are adopting both organic and inorganic strategies to expand globally.
Market Dynamics
Drivers: Technological advancements in PET scanners and radiopharmaceuticals are primary drivers. Companies such as Siemens Healthineers have launched advanced systems like the Biograph Trinion PET/CT scanner, offering AI-powered workflow and integrated patient monitoring, improving diagnostic accuracy and patient comfort. The growing prevalence of cardiovascular diseases, aging population, and preference for non-invasive diagnostics further propel market growth.
Restraints: The high cost of PET/CT systems, ranging from USD 225,000 to USD 750,000, and the shortage of skilled nuclear medicine professionals are significant barriers. Trade protectionism, including tariffs and regulatory requirements in emerging markets, can further delay adoption and increase costs.
Opportunities: Rising demand for advanced imaging systems with faster workflows presents a substantial opportunity. Collaborations between global and local companies, such as IONETIX and Provision Diagnostic Imaging, aim to develop advanced imaging procedures with shorter turnaround times.
Challenges: Limited availability of radiotracers, especially those requiring on-site cyclotrons due to short half-lives, constrains market growth. Supply chain disruptions, regulatory inspections, and maintenance downtimes can delay diagnostic procedures and reduce system utilization.
Market Trends
The market is witnessing a shift toward hybrid imaging systems, such as PET/CT and PET/MRI, which provide superior functional and anatomical resolution. These systems improve assessment of myocardial perfusion and coronary flow reserve. Additionally, AI and software integrations are enhancing diagnostic precision and operational efficiency in cardiac imaging.
Segmentation Analysis
By Source of Payment: The private health insurance/out-of-pocket segment dominates due to better access to personalized treatment and a wider range of service providers. The public insurance segment is expected to grow slowly, limited by insufficient reimbursement policies, though policy reforms such as the 2025 CMS proposal aim to enhance coverage for PET/CT procedures.
By Service Provider: Hospitals retain the largest share due to advanced facilities, trained personnel, and capability to handle complex cardiac procedures. Diagnostic centers are projected to grow at the fastest CAGR because of shorter waiting times, cost-effectiveness, and increasing collaborations with imaging technology providers. Other service providers, such as research institutes and cardiac centers, exhibit stagnant growth due to limited patient preference.
Regional Outlook
- North America: Market value stood at USD 1.13 billion in 2026, driven by high CAD prevalence and investments in advanced diagnostic tools. The U.S. and Canada are leading due to robust healthcare infrastructure and adoption of precision diagnostics.
- Europe: Maintains a significant share due to technological adoption and collaborative initiatives for improving diagnostic efficiency. Investments, such as the UK's USD 334 million allocation for diagnostic digitalization, support growth.
- Asia Pacific: Expected to register the highest CAGR, fueled by rising awareness, government investments, and partnerships for radiopharmaceutical production in countries like China and Japan.
- Latin America: Growth driven by increasing cardiovascular disease prevalence and investments in advanced diagnostics.
- Middle East & Africa: Steady growth due to rising healthcare spending, disposable incomes, and government initiatives for advanced cardiac imaging.
Competitive Landscape
The market is fragmented yet dominated by key players including Sonic Healthcare Limited, Apex Radiology, Siemens Healthcare Limited, and Novant Health, who focus on innovation, strategic partnerships, and distribution expansion. Notable developments include Positron Corporation's PET/CT rental program (2024) and Siemens Healthcare's high-performance PET/CT scanner launch (2024), enhancing operational efficiency and diagnostic precision.
Conclusion
The global cardiology PET scan market is poised for steady growth, from USD 1.93 billion in 2025 to USD 2.83 billion by 2034, driven by technological innovations, rising cardiac disease prevalence, and increasing demand for non-invasive, high-resolution imaging. North America maintains dominance, while Asia Pacific offers the highest growth potential due to increased awareness and investments. Despite challenges like high equipment costs, skilled workforce shortage, and radiotracer availability, the adoption of hybrid imaging systems, AI integration, and private insurance-driven healthcare solutions are expected to sustain market expansion. Leading players focusing on innovation and partnerships will shape the competitive landscape in the coming years.
Segmentation By Source of Payment
- Public
- Private Health Insurance/Out-of-pocket
By Service Provider
- Hospitals
- Diagnostic Centers
- Others
By Geography
- North America (By Source of Payment, Service Provider, and Country)
- U.S.
- Canada
- Europe (By Source of Payment, Service Provider, and Country/Sub-region)
- Germany
- U.K.
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Source of Payment, Service Provider, and Country/Sub-region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Source of Payment, Service Provider, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Source of Payment, Service Provider, and Country/Sub-region)
- GCC
- South Africa
- Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Recent Industry Developments such as Partnerships, Mergers, and Acquisitions
- 4.2. Prevalence of Cardiac Conditions, Key Countries, 2025
- 4.3. New Product Launches
- 4.4. Key Industry Developments, Key Players
5. Global Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Source of Payment
- 5.1.1. Public
- 5.1.2. Private Health Insurance/Out-of-pocket
- 5.2. Market Analysis, Insights and Forecast - By Service Providers
- 5.2.1. Hospitals
- 5.2.2. Diagnostic Centers
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - By Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Latin America
- 5.3.5. Middle East & Africa
6. North America Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Source of Payment
- 6.1.1. Public
- 6.1.2. Private Health Insurance/Out-of-pocket
- 6.2. Market Analysis, Insights and Forecast - By Service Providers
- 6.2.1. Hospitals
- 6.2.2. Diagnostic Centers
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast - By Country
- 6.3.1. U.S.
- 6.3.2. Canada
7. Europe Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Source of Payment
- 7.1.1. Public
- 7.1.2. Private Health Insurance/Out-of-pocket
- 7.2. Market Analysis, Insights and Forecast - By Service Providers
- 7.2.1. Hospitals
- 7.2.2. Diagnostic Centers
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.3.1. U.K.
- 7.3.2. Germany
- 7.3.3. France
- 7.3.4. Spain
- 7.3.5. Italy
- 7.3.6. Scandinavia
- 7.3.7. Rest of Europe
8. Asia pacific Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Source of Payment
- 8.1.1. Public
- 8.1.2. Private Health Insurance/Out-of-pocket
- 8.2. Market Analysis, Insights and Forecast - By Service Providers
- 8.2.1. Hospitals
- 8.2.2. Diagnostic Centers
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.3.1. Japan
- 8.3.2. China
- 8.3.3. India
- 8.3.4. Australia
- 8.3.5. Southeast Asia
- 8.3.6. Rest of Asia Pacific
9. Latin America Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Source of Payment
- 9.1.1. Public
- 9.1.2. Private Health Insurance/Out-of-pocket
- 9.2. Market Analysis, Insights and Forecast - By Service Providers
- 9.2.1. Hospitals
- 9.2.2. Diagnostic Centers
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.3.1. Brazil
- 9.3.2. Mexico
- 9.3.3. Rest of Latin America
10. Middle East & Africa Cardiology Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Source of Payment
- 10.1.1. Public
- 10.1.2. Private Health Insurance/Out-of-pocket
- 10.2. Market Analysis, Insights and Forecast - By Service Providers
- 10.2.1. Hospitals
- 10.2.2. Diagnostic Centers
- 10.2.3. Others
- 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.3.1. GCC
- 10.3.2. South Africa
- 10.3.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. RadNet, Inc.
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Sonic Healthcare Limited
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Akumin Inc.
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Apex Radiology
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Alliance Medical Limited
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Novant Health
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. InHealth Group
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Dignity Health
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Concord Medical
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Siemens Healthcare Limited
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.11. Mediworks
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Strategies
- 11.2.11.6. Financials (Based on Availability)
- 11.2.12. Other Prominent Players
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Strategies
- 11.2.12.6. Financials (Based on Availability)
- 11.2.1. RadNet, Inc.
List of Tables
- Table 1: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
- Table 2: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
- Table 3: Global Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 4: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
- Table 5: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
- Table 6: North America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 7: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
- Table 8: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
- Table 9: Europe Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 10: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
- Table 11: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
- Table 12: Asia Pacific Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 13: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
- Table 14: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
- Table 15: Latin America Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 16: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Source of Payment, 2021-2034
- Table 17: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, by Service Providers, 2021-2034
- Table 18: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Cardiology Positron Emission Tomography Scan Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025 & 2034
- Figure 3: Global Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025 & 2034
- Figure 4: Global Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Region, 2025 & 2034
- Figure 5: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
- Figure 6: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
- Figure 7: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
- Figure 8: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
- Figure 9: North America Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country, 2025 & 2034
- Figure 10: North America Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country, 2025
- Figure 11: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
- Figure 12: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
- Figure 13: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
- Figure 14: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
- Figure 15: Europe Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 16: Europe Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
- Figure 17: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
- Figure 18: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
- Figure 19: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
- Figure 20: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
- Figure 21: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 22: Asia Pacific Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
- Figure 23: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
- Figure 24: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
- Figure 25: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
- Figure 26: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
- Figure 27: Latin America Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 28: Latin America Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
- Figure 29: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Source of Payment, 2025 & 2034
- Figure 30: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), by Source of Payment, 2025
- Figure 31: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), by Service Providers, 2025 & 2034
- Figure 32: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), by Service Providers, 2025
- Figure 33: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 34: Middle East & Africa Cardiology Positron Emission Tomography Scan Market Value Share (%), By Country/ Sub-region, 2025
- Figure 35: Global Cardiology Positron Emission Tomography Scan Market Share (%), By Company, 2025
